🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Simvastatin Krka 20 mg Film Coated Tablets
PA1347/028/002
Simvastatin KRKA, d.d., Novo mesto Marketed
Simvastatin Krka 40 mg Film Coated Tablets
PA1347/028/003
Simvastatin KRKA, d.d., Novo mesto Marketed
Sitagliptin Krka 100 mg film-coated tablets
PA1347/094/003
Sitagliptin KRKA, d.d., Novo mesto Marketed
Sitagliptin Krka 25 mg film-coated tablets
PA1347/094/001
Sitagliptin KRKA, d.d., Novo mesto Marketed
Sitagliptin Krka 50 mg film-coated tablets
PA1347/094/002
Sitagliptin KRKA, d.d., Novo mesto Marketed
Sitagliptin/Metformin hydrochloride Krka 50 mg/1000 mg film-coated tablets
PA1347/100/002
Sitagliptin, Metformin Hydrochloride KRKA, d.d., Novo mesto Marketed
Sitagliptin/Metformin hydrochloride Krka 50 mg/850 mg film-coated tablets
PA1347/100/001
Sitagliptin, Metformin Hydrochloride KRKA, d.d., Novo mesto Marketed
Tadalafil Krka 10 mg film-coated tablets
PA1347/071/003
Tadalafil KRKA, d.d., Novo mesto Marketed
Tadalafil Krka 2.5 mg film-coated tablets
PA1347/071/001
Tadalafil KRKA, d.d., Novo mesto Not marketed
Tadalafil Krka 20 mg film-coated tablets
PA1347/071/004
Tadalafil KRKA, d.d., Novo mesto Marketed
Tadalafil Krka 5 mg film-coated tablets
PA1347/071/002
Tadalafil KRKA, d.d., Novo mesto Not marketed
Tamzeltos 400 micrograms prolonged-release tablets
PA1347/087/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
TANYZ 400 micrograms hard modified-release capsules
PA1347/086/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
Ticagrelor Krka 60 mg film-coated tablets
PA1347/102/001
Ticagrelor KRKA, d.d., Novo mesto Not marketed
Ticagrelor Krka 90 mg film-coated tablets
PA1347/102/002
Ticagrelor KRKA, d.d., Novo mesto Marketed
Tolucombi 40 mg/12.5 mg tablets
EU/1/13/821/001-010
Telmisartan, Hydrochlorothiazide KRKA, d.d., Novo mesto
Tolucombi 80 mg/12.5 mg tablets
EU/1/13/821/011-020
Telmisartan, Hydrochlorothiazide KRKA, d.d., Novo mesto
Tolucombi 80 mg/25 mg tablets
EU/1/13/821/021-030
Telmisartan, Hydrochlorothiazide KRKA, d.d., Novo mesto
Tolura 20 mg tablets
EU/1/10/632/001-7
Telmisartan KRKA, d.d., Novo mesto
Tolura 40 mg tablets
EU/1/10/632/008-14
Telmisartan KRKA, d.d., Novo mesto
Tolura 80 mg tablets
EU/1/10/632/015-21
Telmisartan KRKA, d.d., Novo mesto
Tramadol Krka 50mg hard capsules
PA1347/079/001
Tramadol hydrochloride KRKA, d.d., Novo mesto Marketed
Tramadol/Paracetamol Krka 37.5mg/325mg film-coated tablets
PA1347/052/001
Paracetamol, Tramadol hydrochloride KRKA, d.d., Novo mesto Marketed
Valsartan Krka 160 mg film-coated tablets
PA1347/010/008
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan Krka 320 mg film-coated tablets
PA1347/010/009
Valsartan KRKA, d.d., Novo mesto Not marketed
Valsartan Krka 40 mg film-coated tablets
PA1347/010/006
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan Krka 80 mg film-coated tablets
PA1347/010/007
Valsartan KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/12.5 mg film-coated tablets
PA1347/004/002
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/25 mg film-coated tablets
PA1347/004/003
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/12.5 mg film-coated tablets
PA1347/004/004
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/25 mg film-coated tablets
PA1347/004/005
Valsartan, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Valsartan/hydrochlorothiazide Krka 80 mg/12.5 mg Film-coated Tablets
PA1347/004/001
Hydrochlorothiazide, Valsartan KRKA, d.d., Novo mesto Marketed
Vardenafil Krka 10 mg film-coated tablets
PA1347/073/002
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 20 mg film-coated tablets
PA1347/073/003
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 5mg film-coated tablets
PA1347/073/001
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Venlafex XL 150 mg prolonged-release capsules, hard
PA1347/036/003
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 37.5 mg prolonged-release capsules, hard
PA1347/036/001
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 75 mg prolonged-release capsules, hard
PA1347/036/002
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Vildagliptin Krka 50 mg tablets
PA1347/076/001
Vildagliptin KRKA, d.d., Novo mesto Not marketed
Vizarsin 100 mg film-coated tablets
EU/1/09/551/9-12
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 100 mg orodispersible tablets
EU/1/09/551/023-027
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 25 mg film-coated tablets
EU/1/09/551/1-4
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 25 mg orodispersible tablets
EU/1/09/551/013-017
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 50 mg film-coated tablets
EU/1/09/551/5-8
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 50 mg orodispersible tablets
EU/1/09/551/018-022
Sildenafil KRKA, d.d., Novo mesto
Vortioxetine Krka 10 mg film-coated tablets
PA1347/121/002
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 15 mg film-coated tablets
PA1347/121/003
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 20 mg film-coated tablets
PA1347/121/004
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 5 mg film-coated tablets
PA1347/121/001
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Zalasta 10 mg Orodispersible tablet
EU/1/07/415/42-46
Olanzapine KRKA, d.d., Novo mesto
4 5 6 7 8

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.